We are Elrha, a force for change in the humanitarian community. The research and innovation we support equips the humanitarian community with the knowledge of what works, so people affected by crises get the right help when they need it most.
Our purpose is clear: to empower the humanitarian community to improve humanitarian response. We make this happen by supporting and championing the outcomes of robust research and proven innovations.
We empower the humanitarian community. Find out how we can support you...

What humanitarian need is being addressed?

Since the innovation of RUTF and its scale up in the community based management of acute malnutrition (CMAM), the dosage for treating children with SAM has not been revised despite the perception of scientists and practitioners that children under the current treatment are not reaching the expected weight gain. There is a gap in evidence describing how the current dosage corresponds to the nutritional requirements and the response to treatment of a child with SAM.

What is the innovative solution?

At the invention stage of the innovation, ACF will develop a dosage table which corresponds to the response to treatment in children with SAM and is adapted to their requirements. Since the establishment of RUTF, the dosage for SAM has not been revised and through this product innovation, ACF will contribute to the establishment of an optimized dosage of the existing Product i.e. Ready-to-Use Therapeutic Food (RUTF) for uncomplicated SAM.

How does the innovation build on and improve existing humanitarian practice?

Children with uncomplicated Severe Acute Malnutrition (SAM) are treated with a fixed amount of RUTF per body weight. By following the current protocol of dose by gain of weight, the amount of RUTF to provide increases according to the progressive weight gain until discharge from the programme. However, the dosage of RUTF for SAM treatment has not been reviewed since its establishment and experts nutritionist hypothesize that the energy requirements change throughout treatment and hence that energy intake should be adapted accordingly. Moreover, practitioners perceive that not only children may need less RUTF to recover, but that an optimized dose may reduce the proportion of selling and sharing of the product.

WHAT ARE THE EXPECTED OUTCOMES?

An optimized RUTF dosage table will be established through this project which takes into account the response to treatment of children recovering from SAM. At the implementation stage of the innovation, this dosage table will be piloted in the field through a randomized controlled trial to ensure robust evidence can be collected and used afterwards to justify the scale up of an optimised dosage in CMAM programs.

Latest Updates

A final look at the MANGO Project

Mar 2016

Find out more about MANGO -Modelling an Alternative Nutrition protocol Generalizable for Outpatients.

View
2016Mar

Subscribe to our newsletters....

Subscribe
 
Elrha © 2018 - 2019 Elrha is a registered charity in England and Wales (1177110).
Elrha Please upgrade your browser

You are seeing this because you are using a browser that is not supported. The Elrha website is built using modern technology and standards. We recommend upgrading your browser with one of the following to properly view our website:

Windows Mac

Please note that this is not an exhaustive list of browsers. We also do not intend to recommend a particular manufacturer's browser over another's; only to suggest upgrading to a browser version that is compliant with current standards to give you the best and most secure browsing experience.